Role of Tyr84 in controlling the reactivity of Cys34 of human albumin

FEBS Journal

Volumn 272, Issue 2, 2005, Pages 353-362

  Stewart, Alan J ^a   Blindauer, Claudia A ^a   Berezenko, Stephen ^b   Sleep, Darrell ^b   Tooth, David ^b   Sadler, Peter J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Delta Biotechnology Ltd   (United Kingdom)

Author keywords

Cys34; Disulfide interchange; Human albumin; NMR; Thiol

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); CYSTEINE; DISULFIDE; HISTIDINE; HUMAN ALBUMIN; HYDROXYL GROUP; LEUCINE; MUTANT PROTEIN; PHENYLALANINE; SULFUR; THIOL; TYROSINE;

AMINO ACID SUBSTITUTION; ANTIOXIDANT ACTIVITY; ARTICLE; BINDING SITE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISULFIDE BOND; HYDROGEN BOND; NONHUMAN; OXIDATION REDUCTION POTENTIAL; PH; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY ANALYSIS;

BINDING SITES; DISULFIDES; HUMANS; HYDROGEN-ION CONCENTRATION; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; SERUM ALBUMIN;

EID: 12544259216     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2004.04474.x     Document Type: Article

References (39)

1. Peters T Jr (1995) All About Albumin: Biochemistry, Genetics, and Medical Applications. Academic Press, New York.
2. Carter DC & Ho JX (1994) Structure of serum albumin. Adv Prot Chem 45, 153-203.
3. Curry S, Mandelkow H, Brick P & Franks N (1998) Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol 5, 827-835.
4. Sugio S, Kashima A, Mochizuki S, Noda N & Kobayashi K (1999) Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng 12, 439-446.
5. Pirisino R, Disimplicio P, Ignesti G, Bianchi G & Barbera P (1988) Sulfhydryl groups and peroxidase-like activity of albumin as scavenger of organic peroxides. Pharmacol Res Commun 20, 545-552.
6. Cha MK & Kim IH (1996) Glutathione-linked thiol peroxidase activity of human serum albumin: a possible antioxidant role of serum albumin in blood plasma. Biochem Biophys Res Commun 222, 619-625.
7. 31P nuclear magnetic resonance studies of human blood. J Inorg Biochem 12, 317-322.
8. Roberts JR, Xiao J, Schliesman B, Parsons DJ & Shaw CF III (1996) Kinetics and mechanism of the reaction between serum albumin and auranofin (and its isopropyl analogue) in vitro. Inorg Chem 35, 425-433.
9. Ross SA, Carr CA, Briet JW & Lowe G (2000) Transfer of 4′-chloro-2,2′:6′,2″-terpyridine platinum (II) between human serum albumin, glutathione and other thiolate ligands. A possible selective natural transport mechanism for the delivery of platinum (II) drugs to tumour cells. Anticancer Drug Des 15, 431-439.
10. Esposito BP & Najjar R (2002) Interactions of antitumoral platinum-group metallodrugs with albumin. Coord Chem Rev 232, 137-149.
11. Yasutake A, Hirayama K & Inoue M (1990) Interaction of methylmercury compounds with albumin. Arch Toxicol 64, 639-643.
12. Keire DA, Mariappan SV, Peng J & Rabenstein DL (1993) Nuclear magnetic resonance studies of the binding of captopril and penicillamine by serum albumin. Biochem Pharmacol 46, 1059-1069.
13. Agarwal RP, McPherson RA & Phillips M (1983) Rapid degradation of disulfiram by serum albumin. Res Commun Chem Pathol Pharmacol 42, 293-310.
14. Stamler JS, Jaraki O, Osborne J, Simon DI, Keany J, Vita J, Singel D, Valeri R & Loscalzo J (1992) Nitric oxide circulates in mammalian plasma primarily as an 5-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89, 7674-7677.
15. Kashiba-Iwatsuki M, Miyamoto M & Inoue M (1997) Effect of nitric oxide on the ligand-binding activity of albumin. Arch Biochem Biophys 345, 237-242.
16. Burczynski FJ, Wang GQ & H natowich M (1995) Effect of nitric oxide on albumin-palmitate binding. Biochem Pharmacol 49, 91-96.
17. Glowacki R & Jakubowski H (2004) Cross-talk between Cys34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J Biol Chem 279, 10864-10871.
18. Ashworth MRF (1976) The Determination of Sulphur-Containing Groups. Analytical Methods for Thiol Groups. Vol. 2. Academic Press, London.
19. Pedersen AO & Jacobsen J (1980) Reactivity of the thiol group in human and bovine albumin at pH 3-9, as measured by exchange with 2,2′-dithiodipyridine. Eur J Biochem 106, 291-295.
20. a values. Biochemistry 19, 4156-4166.
21. a of the active site cysteine and the function of the conserved histidine 402. Biochemistry 32, 9340-9345.
22. a and high reactivity of cysteine 145. Biochemistry 42, 10965-10970.
23. a values of active-center cysteines, cysteines-32 and -35, in Escherichia coli thioredoxin by Raman spectroscopy. Biochemistry 32, 5800-5808.
24. Bos OJM, Labro JFA, Fischer MJE, Wilting J & Janssen LHM (1989) The molecular mechanism of the neutral-to-base transition of human serum albumin. Acid/base titration and proton nuclear magnetic resonance studies on a large peptic and a large tryptic fragment of albumin. J Biol Chem 264, 953-959.
25. Lee H, Cha M-K & Kim I-H (2000) Activation of thiol-dependent antioxidant activity of human serum albumin by alkaline pH is due to the B-like conformational change. Arch Biochem Biophys 380, 309-318.
26. Cornell CN & Kaplan LJ (1978) Spin-label studies on the sulfhydryl environment in bovine plasma albumin. 2. The neutral transition and the A isomer. Biochemistry 17, 1755-1758.
27. a of tyrosine-9 and the C-terminal dynamics of glutathione 5-transferase A1-1. Biochemistry 40, 10614-10624.
28. Guddat LW, Bardwell JCA & Martin JL (1998) Crystal structures of reduced and oxidized DsbA: investigation of domain motion and thiolate stabilization. Structure 6, 757-767.
29. Raymond WW, Ruggles SW, Craik CS & Caughey GH (2003) Albumin is a substrate of human chymase. Prediction by combinatorial peptide screening and development of a selective inhibitor based on the albumin cleavage site. J Biol Chem 278, 34517-34524.
30. Satomura K, Yin M, Shimizu S, Kato Y, Nagano T, Komeichi H, Ohsuga M, Katsuta Y, Aramaki T & Omoto Y (2003) Increased chymase in livers with autoimmune disease: colocalization with fibrosis. J Nippon Med Sch 70, 490-495.
31. 1H NMR of albumin in human blood plasma: drug binding and redox reactions at Cys34. FEBS Lett 376, 1-5.
32. Stewart AJ, Blindauer CA, Berezenko S, Sleep D & Sadler PJ (2003) Interdomain zinc site on human albumin. Proc Natl Acad Sci USA 100, 3701-3706.
33. Kunkel TA (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 82, 488-492.
34. Sleep D, Belfield GP, Balance DJ, Steven J, Jones S, Evans LR, Moir PD & Goodey AR (1991) Saccharomyces cerevisiae strains that overexpress heterologous proteins. Biotechnology 9, 183-187.
35. Kerry-Williams SM, Gilbert SC, Evans LR & Ballance DJ (1997) Disruption of the Saccharomyces cerevisiae YAP3 gene reduces the proteolytic degradation of secreted recombinant human albumin. Yeast 14, 161-169.
36. Wilson JM, Wu D, Motiu-DeGrood R & Hupe DJ (1980) A spectroscopic method for studying the rates of reaction of disulfides with protein thiol-groups applied to bovine serum albumin. J Am Chem Soc 102, 359-363.
37. Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82, 70-77.
38. Glasoe PK & Long FA (1960) Use of glass electrodes to measure acidities in deuterium oxide. J Phys Chem 64, 188-190.
39. Brocklehurst K & Little G (1973) Reactions of papain and of low-molecular-weight thiols with some aromatic disulphides. 2,2′-Dipyridyl disulphide as a convenient active-site titrant for papain even in the presence of other thiols. Biochem J 133, 67-80.